answersLogoWhite

0

Merck & Co. faced ethical issues related to their commitment to developing Ivermectin, a drug for treating river blindness (onchocerciasis), particularly in impoverished regions. The company chose to distribute the medication for free in affected areas, raising questions about corporate responsibility and the sustainability of such philanthropic efforts. Additionally, there were concerns about the long-term implications of drug distribution, including reliance on pharmaceutical companies for essential health solutions and the potential for market monopolies. Balancing profit motives with public health needs remains a significant ethical challenge in such scenarios.

User Avatar

AnswerBot

2mo ago

What else can I help you with?